Featured Posts
National Review
Prescription Drugs Save Lives at a (Mostly) Reasonable Cost
Prescription drugs are an extraordinary lifesaving and life-enhancing technology, so integrated into our daily lives that, nowadays, we perhaps take them for granted. Headlines and…
News Release
FDA deserves credit for approval pancreatic cancer drug
The FDA on August 26 approved a new breakthrough drug to treat pancreatic cancer. CEI Senior Fellow and Economist Jeremy Nighohossian praised…
Blog
Fauci’s lasting legacy will be the damage he did to science and government
Anthony Fauci isn’t faring well in the court of public opinion. His recently divulged “diary” and subsequent July 29 appearance before the Senate Homeland…
Search Posts
The Wall Street Journal
Latest Legal Challenges to the Health Law: A Guide
A fourth lawsuit is pending in Virginia. That case, as well as the one in Washington, is in the hands of Michael A. Carvin, a…
The Wall Street Journal
Obamacare’s Next Bout: More Legal Challenges
The Competitive Enterprise Institute (CEI) took the primary lead in finding funding and potential plaintiffs, as well as coordinating future…
The Wall Street Journal
Health Law Faces New Legal Challenges
The Competitive Enterprise Institute, a libertarian think tank, is coordinating the suits and helping with their legal costs, a spokeswoman said…
Legal Brief
Affordable Care Act Lawsuit – October 4 Reply Memorandum in Support of Plaintiffs’ Motion for Preliminary Injunction and/or Summary Judgment
Full Document Available in PDF At long last, the Government has filed a brief defending the IRS Rule on the merits. (Dkt.
Legal Brief
Affordable Care Act Lawsuit – October 4 Supplemental Declaration in Support of Preliminary Injunction
Full Document Available in PDF In my declaration of August 5, 2013, I attested that I did not wish to purchase comprehensive…
The Washington Times
EDITORIAL: Obamacare’s fatal flaw
Michael Carvin, who argued the Supreme Court’s Obamacare cases last year, is working with the Competitive Enterprise Institute to reverse the agency’s decision. “The…